Charles County deputies search for missing 86-year-old man with Alzheimer’s disease
Deputies in Charles County are looking for an 86-year-old man after he went missing from a Waldorf home. In a post on the X ...
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
Earliest sign of Alzheimer's disease appear in your dreams - and one gadget can help you track it
Researchers believe that those who take longer to enter the dream phase of sleep may be at higher risk of Alzheimer's disease ...
How your dreams can tell you if you’re at greater risk for dementia
Recent studies have shown that both the quality and the amount of sleep we get may influence our risk of developing Alzheimer ...
UK clinic is first in Europe to offer two Alzheimer's wonder drugs privately
A London clinic has become the first in Europe to offer both Alzheimer’s wonder drugs privately after they were rejected for ...
Dreams can give early sign of Alzheimer's disease - and one item can help you track it
A new study has revealed that the time it takes for you to reach the dream phase of sleep, known as rapid eye movement (REM) ...
Rolling Out21h
Alzheimer’s new nasal spray stops memory loss
Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...
Red meat could raise dementia risk, researchers claim, yet some doctors have questions
Researchers have linked daily consumption of certain amounts of processed red meats to increased dementia risk, but some ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
INDICATION LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with ...
STAT2h
U.S. health agencies see some chaos — but an FDA approval gets through
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Intelligence is linked to a 'swifter death from dementia', research indicates
Those who spend longer in education typically have brain 'reserves' helping them fend off early symptoms, a review of ...
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...